C-RAD AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0002016352
SEK
31.25
-2.9 (-8.49%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
469.00
424.62
301.33
261.15
221.63
205.39
190.11
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
469.00
424.62
301.33
261.15
221.63
205.39
190.11
Raw Material Cost
392.73
371.36
280.72
224.81
202.94
198.91
183.61
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
140.29
136.87
103.34
71.70
64.85
63.93
59.27
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.28
0.38
0.43
0.27
0.74
1.75
0.97
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
-19.30
-13.20
Other Expenses
-13.45
-13.30
-9.93
-7.20
-6.56
-4.11
-4.32
Total Expenditure (Excl Depreciation)
398.76
375.63
285.24
224.81
202.94
204.24
187.49
Operating Profit (PBDIT) excl Other Income
70.19999999999999
49
16.1
36.3
18.700000000000003
1.2
2.6
Other Income
9.70
-4.92
5.84
-0.34
-1.54
1.15
-0.95
Operating Profit (PBDIT)
83.79
48.67
27.51
45.71
26.15
6.02
3.50
Interest
0.28
0.38
0.43
0.27
0.74
1.75
0.97
Exceptional Items
0.12
0.23
0.00
0.00
0.00
-10.90
-0.15
Gross Profit (PBDT)
76.27
53.25
20.61
36.34
18.68
6.48
6.50
Depreciation
3.85
4.60
5.59
9.71
9.03
4.74
2.18
Profit Before Tax
79.78
43.93
21.49
35.74
16.38
-11.37
0.21
Tax
23.33
8.40
14.01
10.64
2.02
2.43
-20.98
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
56.45
35.53
7.48
25.10
14.37
-13.80
21.19
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
56.45
35.53
7.48
25.10
14.37
-13.80
21.19
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
56.45
35.53
7.48
25.10
14.37
-13.80
21.19
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.15
0.15
0.15
0.15
0.15
0.15
0.15
Reserves
324.99
271.18
242.54
231.09
199.79
83.33
93.64
Earnings per share (EPS)
1.67
1.05
0.22
0.74
0.43
-0.45
0.68
Diluted Earnings per share
1.67
1.05
0.22
0.74
0.43
-0.45
0.68
Operating Profit Margin (Excl OI)
14.98%
11.54%
5.34%
13.92%
8.42%
0.06%
1.2%
Gross Profit Margin
17.83%
11.43%
8.99%
17.4%
11.47%
-3.23%
1.26%
PAT Margin
12.04%
8.37%
2.48%
9.61%
6.48%
-6.72%
11.15%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 10.46% vs 40.92% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 58.87% vs 373.33% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 38.25% vs 147.00% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is -25.00% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of C-RAD AB With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Net Sales
469.00
55.67
413.33
742.46%
Other Operating Income
0.00
0.00
0.00
Total Operating income
469.00
55.67
413.33
742.46%
Raw Material Cost
392.73
69.88
322.85
462.01%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
140.29
40.22
100.07
248.81%
Power Cost
0
0
0.00
Manufacturing Expenses
0.28
0.08
0.20
250.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
-13.45
-3.47
-9.98
-287.61%
Total Expenditure (Excl Depreciation)
398.76
75.48
323.28
428.30%
Operating Profit (PBDIT) excl Other Income
70.24
-19.81
90.05
454.57%
Other Income
9.70
3.96
5.74
144.95%
Operating Profit (PBDIT)
83.79
-14.54
98.33
676.27%
Interest
0.28
0.08
0.20
250.00%
Exceptional Items
0.12
0.00
0.12
Gross Profit (PBDT)
76.27
-14.21
90.48
636.73%
Depreciation
3.85
1.31
2.54
193.89%
Profit Before Tax
79.78
-15.93
95.71
600.82%
Tax
23.33
0.15
23.18
15,453.33%
Provisions and contingencies
0
0
0.00
Profit After Tax
56.45
-16.08
72.53
451.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
56.45
-16.08
72.53
451.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
56.45
-16.08
72.53
451.06%
Equity Capital
0
0
0.00
Face Value
0.15
0.02
0.00
Reserves
324.99
101.23
223.76
221.04%
Earnings per share (EPS)
1.67
-0.39
2.06
528.21%
Diluted Earnings per share
1.67
-0.39
2.06
528.21%
Operating Profit Margin (Excl OI)
14.98%
-35.59%
0.00
50.57%
Gross Profit Margin
17.83%
-26.26%
0.00
44.09%
PAT Margin
12.04%
-28.89%
0.00
40.93%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 46.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.46% vs 40.92% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 5.64 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 58.87% vs 373.33% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.41 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 38.25% vs 147.00% in Dec 2023

Annual - Interest
Interest 0.03 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -25.00% vs 0.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.98%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023